Arthur David J.
Insider CIK 1769331 · SLRX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2024-04-11 | 2024-04-12 | 20,500 | — | $0 | 20,500 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2023-02-13 | 2023-02-15 | 14,300 | — | $0 | 48,019 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2023-01-03 | 2023-01-05 | 20,000 | — | $0 | 33,719 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-11-03 | 2022-11-07 | 10,000 | $1.73 | $17.3K | 285,674 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-11-03 | 2022-11-08 | 10,000 | $1.73 | $17.3K | 21,026 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-11-03 | 2022-12-12 | 2,693 | $1.73 | $4.7K | 13,719 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-05-26 | 2022-05-31 | 708 | $0.18 | $127 | 282,382 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-05-26 | 2022-05-31 | 18,600 | $0.18 | $3.3K | 281,674 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-05-26 | 2022-05-31 | 3,400 | $0.18 | $612 | 263,074 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-05-26 | 2022-05-31 | 10,800 | $0.18 | $1.9K | 303,574 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-05-26 | 2022-05-31 | 10,392 | $0.18 | $1.9K | 292,774 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2022-05-03 | 2022-05-05 | 10,000 | $0.19 | $1.9K | 259,674 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-03-03 | 2022-03-09 | 139,488 | $0.39 | $54.4K | 249,674 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2022-01-20 | 2022-01-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2021-11-03 | 2021-11-05 | 7,939 | $0.72 | $5.7K | 110,186 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2021-08-17 | 2021-08-17 | 2,000 | $0.89 | $1.8K | 102,247 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2021-08-17 | 2021-08-17 | 2,000 | $0.90 | $1.8K | 100,247 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2021-05-03 | 2021-05-05 | 9,822 | $0.57 | $5.6K | 96,247 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-12-02 | 2020-12-04 | 275,000 | — | $0 | 275,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2020-11-03 | 2020-11-05 | 4,879 | $0.56 | $2.7K | 86,425 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-08-19 | 2020-08-20 | 1,000 | $1.01 | $1.0K | 2,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-08-19 | 2020-08-20 | 1,000 | $1.01 | $1.0K | 1,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-07-14 | 2020-07-16 | 339,584 | — | $0 | 339,584 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-03-23 | 2020-03-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy deriv | 2020-02-11 | 2020-02-13 | 2,175 | $0.01 | $22 | 2,175 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-02-11 | 2020-02-12 | 2,175 | $1.15 | $2.5K | 81,546 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2019-09-10 | 2019-09-13 | 30,000 | — | $0 | 30,000 | SEC↗ |